PofoliaShared via Pofolia

Surgical Infections· 2012Q2

Disseminated <i>Nocardia farcinica</i> : Literature Review and Fatal Outcome in an Immunocompetent Patient

Jonathan M. Budzik, Mojgan Hosseini, Alexander C. Mackinnon, Jerome B. Taxy

Short summary

Disseminated Nocardia farcinica, typically linked to immunocompromise (88% of cases with malignancy or autoimmune disease), can be fatal even in immunocompetent individuals, as demonstrated by a case of sepsis with lung and synovium infection.

AI-generated from the title and abstract; the full text is not read.

Key points

  • Disseminated Nocardia farcinica is strongly associated with underlying malignancy or autoimmune disease (88% of patients).
  • A fatal case of N. farcinica sepsis occurred in an immunocompetent patient with no known risk factors.
  • Post-mortem cultures from lung and synovium confirmed N. farcinica infection, correlating with bronchopneumonia and synovitis.
  • The mortality rate for N. farcinica in recent literature is 39%, an increase from earlier reports.

AI-generated from the title and abstract; the full text is not read.

Abstract

BACKGROUND: Nocardia farcinica is a gram-positive, partially acid-fast, methenamine silver-positive aerobic actinomycete. Nocardia spp. are opportunistic pathogens, and N. farcinica is the least common species of clinical importance. METHODS: Review of the recent literature and description of a immunocompetent patient with no known risk factors who contracted fatal N. farcinica sepsis. RESULTS: Positive pre-mortem and post-mortem cultures from the lung and synovium correlated with acute bronchopneumonia and synovitis at autopsy. Colonies of filamentous bacteria, which were not apparent in conventional hematoxylin and eosin-stained sections, were observed with gram and methenamine silver stains, but acid-fast stains were negative. A literature review revealed that disseminated N. farcinica often is associated with an underlying malignant tumor or autoimmune disease (88% of patients). Chemotherapy or corticosteroid treatments are additional risk factors. CONCLUSIONS: Trimethoprim-sulfamethoxazole typically is the first-line therapy for N. farcinica; treatment with amikacin and imipenem-cilastatin is used less often (7% of patients). Despite aggressive therapy, we observed that the death rate (39%) associated with N. farcinica in recent publications was eight percentage points higher than reported in a review from 2000.

The authors' abstract, as published at the source. Surgical Infections, 2012 · DOI ↗

TakeawaysPremium
Ask the paperFree account

Continue with a free account

Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.

Continue free on the web

Sign in with Google or Apple; no card needed. You come back to this paper.

On your phone:

Field: Microbiology

MicrobiologyMedicine